Efficacy and safety of dapagliflozin in patients with type 2 diabetes on insulin ± metformin regimens

被引：0
|
作者：
Yeh, H. [1 ]
Katz, A. [1 ]
机构：
[1] AstraZeneca, Ft Washington, MD USA
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
744
引用
收藏
页码：S357 / S357
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes on Insulin ± Metformin Regimens
    Katz, Arie
    Yeh, Helen
    [J]. DIABETES, 2015, 64 : A317 - A317
  • [2] Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
    Mueller-Wieland, Dirk
    Kellerer, Monika
    Cypryk, Katarzyna
    Skripova, Dasa
    Rohwedder, Katja
    Johnsson, Eva
    Garcia-Sanchez, Ricardo
    Kurlyandskaya, Raisa
    Sjostrom, C. David
    Jacob, Stephan
    Seufert, Jochen
    Dronamraju, Nalina
    Csomos, Katalin
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2598 - 2607
  • [3] Efficacy and safety of dapagliflozin in Asian patients with type 2 diabetes after metformin failure: A randomized controlled trial
    Yang, Wenying
    Han, Ping
    Min, Kyung-Wan
    Wang, Bei
    Mansfield, Traci
    T'Joen, Caroline
    Iqbal, Nayyar
    Johnsson, Eva
    Ptaszynska, Agata
    [J]. JOURNAL OF DIABETES, 2016, 8 (06) : 796 - 808
  • [4] Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years
    Wilding, J. P. H.
    Woo, V.
    Rohwedder, K.
    Sugg, J.
    Parikh, S.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (02): : 124 - 136
  • [5] Efficacy and Safety of Saxagliptin Added to Insulin With or Without Metformin in Chinese Patients with Type 2 Diabetes
    Chen, Yingli
    Liu, Xiaomin
    Li, Quanmin
    Ma, Jianhua
    Lv, Xiaofeng
    Guo, Lixin
    Wang, Changjiang
    Shi, Yongquan
    Li, Yanbing
    Johnsson, Eva
    Wang, Mei
    Zhao, June
    Ji, Linong
    [J]. DIABETES, 2017, 66 : A329 - A329
  • [6] Efficacy and safety of dapagliflozin combined with insulin in overweight or obese individuals with type 2 diabetes
    Li, Xiaolong
    Sun, Dianjing
    Zhang, Yan
    Gu, Wei
    Zheng, Kunjie
    [J]. PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 36 (04) : 1349 - 1354
  • [7] Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes: Outcomes by Race and Ethnicity
    Moran, Jason
    Yeh, Helen
    Katz, Arie
    [J]. DIABETES, 2015, 64 : A315 - A315
  • [8] Efficacy and Safety of Dapagliflozin as Monotherapy for Type 2 Diabetes Mellitus in Japanese Patients
    Kaku, Kohei
    Inoue, Satoshi
    Matsuoka, Osamu
    Kiyosue, Arihiro
    Azuma, Haruna
    Hayashi, Nobuya
    Tokudome, Takuto
    Langkilde, Anna Maria
    Parikh, Shamik
    [J]. DIABETES, 2012, 61 : A260 - A260
  • [9] Efficacy and safety of dapagliflozin in patients with type 2 diabetes and concomitant heart failure
    Kosiborod, Mikhail
    Gause-Nilsson, Ingrid
    Xu, John
    Sonesson, Christian
    Johnsson, Eva
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (07) : 1215 - 1221
  • [10] Evaluating the Efficacy, Safety, and Tolerability of Combination Therapy of Dapagliflozin and Linagliptin Over Dapagliflozin and Vildagliptin in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
    Dharmalingam, Mala
    Sharma, Surendra Kumar
    Prakash, Ved
    Maiti, Animesh
    Kumar, Ritesh
    Murthy, Laxminarayanappa Sreenivasa S.
    Ramanathan, Balamurugan
    Maheshwari, Sanjiv
    Kethavath, Sunil Naik
    Ogale, Dhananjay
    Bachubhai, Prajapati Vipul Kumar
    Sonawane, Ashutosh B.
    Shah, Vaishal
    Suresh, Manjula
    Chakraborty, Sisir
    Manjunath, Krishna Kumar
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
12345